BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
BCRX earnings call for the period ending March 31, 2024.
Source: fool.com
📰 John Bluth News
John Bluth News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Bluth. Real-time updates on events, politics, business and more.
BioCryst to Report First Quarter 2024 Financial Results on May 6 - BioCryst Pharma (NASDAQ:BCRX)
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2024 financial results on Monday, May 6,
Source: benzinga.com
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
BCRX earnings call for the period ending December 31, 2023.
Source: fool.com
BioCryst Launches ORLADEYO® (berotralstat) in Italy
RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 -- BioCryst Pharmaceuticals, Inc. today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco , has finalized reimbursement and...
Source: marketscreener.com
BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 -- BioCryst Pharmaceuticals, Inc. today announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on...
San Francisco United States John Bluth Globenewswire Inc Biocryst Pharmaceuticals Biocryst Pharmaceuticals Inc
Source: marketscreener.com
BioCryst to Present at Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., Nov. 21, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 6th Annual Evercore ISI HealthCONx Conference
United States New York John Bluth Biocryst Pharmaceuticals Biocryst Pharmaceuticals Inc Cryst Pharmaceuticals
Source: eagletribune.com
BioCryst Presents New Real-world Data Showing Reduced Attack Rates in Patients with HAE with ...
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new analyses of real-world use of oral, once-daily ORLADEYO® (berotralstat) leading to a
United States H James Wedner Bryan Arnold John Bluth Anaheim Convention Center Biocryst Pharmaceuticals
Source: eagletribune.com
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
BCRX earnings call for the period ending September 30, 2023.
Source: fool.com
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the BioCryst Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
Source: insidermonkey.com
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Oct. 04, 2023 -- BioCryst Pharmaceuticals, Inc. today announced that the compensation committee of BioCryst’s board of directors granted 23 newly-hired employees...
United States John Bluth Globenewswire Inc Biocryst Pharmaceuticals Inc Biocryst Pharmaceuticals Inc Nasdaq Biocryst Pharmaceuticals
Source: marketscreener.com